Cargando…
NKL-Code in Normal and Aberrant Hematopoiesis
SIMPLE SUMMARY: Gene codes represent expression patterns of closely related genes in particular tissues, organs or body parts. The NKL-code describes the activity of NKL homeobox genes in the hematopoietic system. NKL homeobox genes encode transcription factors controlling basic developmental proces...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073162/ https://www.ncbi.nlm.nih.gov/pubmed/33921702 http://dx.doi.org/10.3390/cancers13081961 |
_version_ | 1783684070509641728 |
---|---|
author | Nagel, Stefan |
author_facet | Nagel, Stefan |
author_sort | Nagel, Stefan |
collection | PubMed |
description | SIMPLE SUMMARY: Gene codes represent expression patterns of closely related genes in particular tissues, organs or body parts. The NKL-code describes the activity of NKL homeobox genes in the hematopoietic system. NKL homeobox genes encode transcription factors controlling basic developmental processes. Therefore, aberrations of this code may contribute to deregulated hematopoiesis including leukemia and lymphoma. Normal and abnormal activities of NKL homeobox genes are described and mechanisms of (de)regulation, function, and diseases exemplified. ABSTRACT: We have recently described physiological expression patterns of NKL homeobox genes in early hematopoiesis and in subsequent lymphopoiesis and myelopoiesis, including terminally differentiated blood cells. We thereby systematized differential expression patterns of eleven such genes which form the so-called NKL-code. Due to the developmental impact of NKL homeobox genes, these data suggest a key role for their activity in normal hematopoietic differentiation processes. On the other hand, the aberrant overexpression of NKL-code-members or the ectopical activation of non-code members have been frequently reported in lymphoid and myeloid leukemia/lymphoma, revealing the oncogenic potential of these genes in the hematopoietic compartment. Here, I provide an overview of the NKL-code in normal hematopoiesis and instance mechanisms of deregulation and oncogenic functions of selected NKL genes in hematologic cancers. As well as published clinical studies, our conclusions are based on experimental work using hematopoietic cell lines which represent useful models to characterize the role of NKL homeobox genes in specific tumor types. |
format | Online Article Text |
id | pubmed-8073162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80731622021-04-27 NKL-Code in Normal and Aberrant Hematopoiesis Nagel, Stefan Cancers (Basel) Review SIMPLE SUMMARY: Gene codes represent expression patterns of closely related genes in particular tissues, organs or body parts. The NKL-code describes the activity of NKL homeobox genes in the hematopoietic system. NKL homeobox genes encode transcription factors controlling basic developmental processes. Therefore, aberrations of this code may contribute to deregulated hematopoiesis including leukemia and lymphoma. Normal and abnormal activities of NKL homeobox genes are described and mechanisms of (de)regulation, function, and diseases exemplified. ABSTRACT: We have recently described physiological expression patterns of NKL homeobox genes in early hematopoiesis and in subsequent lymphopoiesis and myelopoiesis, including terminally differentiated blood cells. We thereby systematized differential expression patterns of eleven such genes which form the so-called NKL-code. Due to the developmental impact of NKL homeobox genes, these data suggest a key role for their activity in normal hematopoietic differentiation processes. On the other hand, the aberrant overexpression of NKL-code-members or the ectopical activation of non-code members have been frequently reported in lymphoid and myeloid leukemia/lymphoma, revealing the oncogenic potential of these genes in the hematopoietic compartment. Here, I provide an overview of the NKL-code in normal hematopoiesis and instance mechanisms of deregulation and oncogenic functions of selected NKL genes in hematologic cancers. As well as published clinical studies, our conclusions are based on experimental work using hematopoietic cell lines which represent useful models to characterize the role of NKL homeobox genes in specific tumor types. MDPI 2021-04-19 /pmc/articles/PMC8073162/ /pubmed/33921702 http://dx.doi.org/10.3390/cancers13081961 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Nagel, Stefan NKL-Code in Normal and Aberrant Hematopoiesis |
title | NKL-Code in Normal and Aberrant Hematopoiesis |
title_full | NKL-Code in Normal and Aberrant Hematopoiesis |
title_fullStr | NKL-Code in Normal and Aberrant Hematopoiesis |
title_full_unstemmed | NKL-Code in Normal and Aberrant Hematopoiesis |
title_short | NKL-Code in Normal and Aberrant Hematopoiesis |
title_sort | nkl-code in normal and aberrant hematopoiesis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073162/ https://www.ncbi.nlm.nih.gov/pubmed/33921702 http://dx.doi.org/10.3390/cancers13081961 |
work_keys_str_mv | AT nagelstefan nklcodeinnormalandaberranthematopoiesis |